Lourdes Basabe, Director of the Microfluidics & Biomics Cluster
UPV/EHU, participated in BIOSPAIN 2026, one of Europe’s leading
international events in biotechnology and life sciences, held at the
Bilbao Exhibition Centre (BEC) from 29 September to 1 October.
As part of the BIOSPAIN programme, Lourdes Basabe participated on 29
September in the roundtable “Choosing the Basque Country to Grow Your
Business in Life Sciences and Health – Discover the Reasons”, held at
the Margarita Salas Auditorium. Link to BIOSPAIN 2026: Home - BIOSPAIN
2026. Bilbao. Spain
The session brought together different perspectives on the factors
that make the Basque Country an attractive environment for developing
and scaling businesses in the life sciences and health sectors. The
discussion addressed the importance of a strong innovation ecosystem,
public-private collaboration, scientific and technological
capabilities, access to investment, talent and the connection between
research and industry.
The roundtable was moderated by María Aguirre, Head of Health and
Sociohealth Transition at SPRI, and included Fermín Goytisolo Gil,
Partner at Itua Health – Eikonoklastes Therapeutics; Javier García
Cogorro, General Partner at Columbus Venture Partners; Idoia Muñoz
Lizán, Managing Director of the Basque Health Cluster; and Lourdes
Basabe, Director of the Microfluidics & Biomics Cluster UPV/EHU.
Link to event: Agenda - BIOSPAIN 2026. Bilbao. Spain
Connecting research, technology and business
During the discussion, Lourdes Basabe contributed the perspective of
academic research and deep-tech development, highlighting the
importance of creating effective connections between scientific
knowledge, technological development, talent, industry and investment.
Her participation also provided an opportunity to showcase the
experience of the Microfluidics & Biomics Cluster UPV/EHU in
developing innovative microfluidic technologies and translating
research results towards applications in biomedicine, diagnostics and
other fields.
The Cluster brings together research capabilities in microfluidics,
biosensing, functional materials, cell-based systems and the
integration of miniaturised technologies. Its activity combines
fundamental and applied research with collaboration with companies,
healthcare organisations, technology centres and other research
institutions, with a strong focus on technology transfer and the
development of new applications.
For Basabe, the ability to move from scientific discovery to
technological solutions and ultimately to new products, services and
companies depends not only on excellent research, but also on the
availability of a connected ecosystem capable of supporting the entire
innovation pathway.
Euskadi as an environment for life sciences innovation
BIOSPAIN 2026 brings together companies, researchers, investors,
public institutions and other stakeholders from across the
biotechnology and life sciences ecosystem. The event provides an
important international platform for showcasing the capabilities of
the Basque Country and for fostering new collaborations and business opportunities.
The Basque life sciences ecosystem currently includes more than 300
companies, supported by a broad network of universities, research
organisations, technology centres, healthcare institutions and other
innovation actors.
Participation in BIOSPAIN 2026 therefore provided an opportunity to
highlight the role of university research and deep-tech technologies
within this ecosystem, while reinforcing the importance of
collaboration between science, industry, investment and public
institutions in transforming research excellence into innovation and
economic impact.
For the Microfluidics & Biomics Cluster UPV/EHU, participation in
the event represents another step in strengthening its international
visibility and its connections with the wider life sciences and health
ecosystem, both in the Basque Country and internationally.